Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Dermatologic 1

Conditions

Squamous Intraepithelial Lesions 1Skin Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

pembrolizumab 3Biopsy 2Aminolevulinic Acid 2pertuzumab 1osimertinib 1liposomal doxorubicin 1cobimetinib 1cemiplimab 1cc-486 1Trastuzumab 1Tissue Banks 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Solutions 1Red Light 1Quality of Life 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1Observation 1Molecular Diagnostic Techniques 1Mass Screening 1Magnetic Resonance Spectroscopy 1Isotretinoin 1Interleukin-2 1Interferon-alpha 1Injections 1Immunotherapy 1Immunohistochemistry 1IT-101 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Skin Neoplasms × Blue Light × Gynecologic × Clear all
NCT06159842 2025-02-12

Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)

The Center for Clinical and Cosmetic Research

Phase 2 Completed
32 enrolled
DermatologicGynecologic

Squamous Intraepithelial Lesions, Carcinoma, Squamous Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡